acute [tmco]
effects [qlco]
Nicorandil [orch, phsu]
Glucose tolerance [phsf]
Subject [grup]
Borderline [qlco]
Fasting blood glucose level [lbpr]
acute [tmco]
Effect [qlco]
Ischaemic [ftcn]
Potassium Channel Opener [phsu]
Nicorandil [orch, phsu]
Glucose tolerance [phsf]
Post [tmco]
Challenge [clna]
insulin levels [lbpr]
investigated [ftcn]
Subject [grup]
Males [fndg]
Females [fndg]
Age-Years [tmco]
Borderline [qlco]
Fasting blood glucose [lbpr]
Single [popg]
blinded study [resa]
Submitted [ftcn]
To [qlco]
Two [qnco]
Oral Glucose Tolerance Test [diap]
Order [inpr]
Premedication [topp]
Once [inpr]
Administration, Oral [topp]
mg% [qnco]
Nicorandil [orch, phsu]
This [euka]
Single [popg]
Dose [qnco]
Nicorandil [orch, phsu]
increased blood glucose [fndg]
Level [qlco]
minute [tmco]
mg dl [qnco]
P NOS [aapp, imft]
minute [tmco]
mg dl [qnco]
P NOS [aapp, imft]
Ingestion [biof]
mg% [qnco]
Glucose [bacs, carb, phsu]
Serum insulin level [lbpr]
Not [ftcn]
Altered [ftcn]
Conclusion [idcn]
Suggest [idcn]
Controlled Study [resa]
Patients [podg]
coronary artery disease [dsyn]
Performed [ftcn]
To [qlco]
investigate [ftcn]
long-term treatment [hlca]
Nicorandil [orch, phsu]
Increase [ftcn]
progression [patf]
Rate [acty]
Impaired glucose tolerance [dsyn]
Normal [qlco]
Impaired glucose tolerance [dsyn]
Possibly [qlco]
Negative [qlco]
IMPACT [gngm]
Course [tmco]
Cardiovascular disease [dsyn]
Conventional [qlco]
Anti-anginal [phsu]
Drugs [phsu]
